西比灵辅助治疗脑梗死后眩晕的临床观察

Effect of Sibelium on Vertigo Patients after Cerebral Infarction

目的 :探讨西比灵辅助治疗脑梗死后眩晕的临床机制和治疗效果。方法 :脑梗死后眩晕 82例随机分为治疗组 (43例 )和对照组 (39例 )。对照组按病情分别予抗凝、溶栓、降压、降血糖及营养脑神经等常规治疗 ;在此基础上治疗组加服西比灵胶囊。治疗 1个月后进行疗效评定。结果 :治疗组治疗后纤维蛋白原、血小板粘附率降低 ,凝血酶原时间延长 ,眩晕总有效率 97 6 % ,均优于对照组。结论 :西比灵辅助治疗脑梗死后眩晕安全有效。

Objective:To evaluate the effect of Sibelium on vertigo patients after cerebral infarction(CI).Methods: Eighty_two vertigo patients with CI were randomly divided into the Sibelium treating group(43 cases)and the control group(39 cases).The control group was given anticoagulant,plasminogen, and drugs to reduce blood pressure.On the basis of routime treatment, Sibelium(5mg,qN,for one month)was given in the treating group.Results:The treating group showed a statistically effective rate of 97 6%(P<0 01).Conclusion:Sibelium is effective in the treatment of vertigo patients after cerebral infarction.